Incruse Ellipta Inhaler 62.5mcg and/or Equivalents
Incruse Ellipta Inhaler 62.5mcg

Marketed as Incruse Ellipta Inhaler 55mcg in the United Kingdom
Manufactured by: Glaxosmithkline
This product is offered for sale by a Licensed Pharmacy located in the United Kingdom
From $2.71 USD/dose
CAN NOT BE SPLIT Must be taken in existing form.
No Generic Alternative Available
No generic alternative is available for this drug.
More Brand Products
Product | Lowest Unit Price |
---|---|
Incruse Ellipta Inhaler 62.5mcg
Marketed as Incruse Ellipta Inhaler 55mcg in the United Kingdom — Manufactured by: Glaxosmithkline |
$2.71 USD/dose |
Incruse Ellipta Inhaler 62.5mcg
Marketed as Incruse Ellipta Inhaler 62.5mcg in New Zealand — Manufactured by: Glaxosmithkline |
$3.15 USD/dose |
Incruse Ellipta Inhaler 62.5mcg
Marketed as Incruse Ellipta Inhaler 62.5mcg in Australia — Manufactured by: Glaxosmithkline |
$3.12 USD/dose |
Incruse Ellipta Inhaler 62.5mcg
Marketed as Incruse Ellipta Inhaler 55mcg in the United Kingdom — Manufactured by: Glaxosmithkline |
$2.74 USD/dose |
Incruse Ellipta Inhaler 62.5mcg
Marketed as Incruse Ellipta Inhaler 55mcg in Canada — Manufactured by: Glaxosmithkline |
$2.81 USD/dose |
No generic alternatives are available for this drug.